Puma Biotechnology PBYI
NASDAQ PBYI
$9.51 -0.33 (-3.35%)
At close: Oct 2, 2026 · 4:00 PM EDT

Puma Biotechnology (PBYI) Amortization of Deferred Charges (2015)

Updated

Puma Biotechnology's Amortization of Deferred Charges came in at $3 million for FY2016, compared with $179,000 in FY2015.

Analysis

Puma Biotechnology (PBYI) Amortization of Deferred Charges (2015) Analysis & Trends

  • Per Business Quant, earlier years put Amortization of Deferred Charges at $179,000 in FY2015 (-6.8%) and $192,000 in FY2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,076.25 Bn 1,044.84 Bn 19.71 Bn
2 Johnson & Johnson 617.18 Bn 535.70 Bn 17.26 Bn
3 AbbVie 464.58 Bn 437.73 Bn 12.70 Bn
4 Merck 356.04 Bn 310.47 Bn 12.21 Bn
5 Novartis Ag 269.07 Bn 224.94 Bn 11.24 Bn
6 Astrazeneca 243.21 Bn 216.77 Bn 12.86 Bn
7 Amgen 217.88 Bn 173.28 Bn 7.24 Bn
8 Gilead Sciences 179.62 Bn 153.74 Bn 6.22 Bn
9 Pfizer 158.45 Bn 105.40 Bn 10.94 Bn
10 Puma Biotechnology 485.99 Mn 98.62 Mn 44.03 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2015 179,000.00
API Access

Puma Biotechnology Amortization of Deferred Charges API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=amortization-of-deferred-charges&ticker=PBYI&period=max&api_key=YOUR_API_KEY